Active Ingredient: ABARELIX
Proprietary Name: PLENAXIS
Dosage Form; Route of Administration: INJECTABLE; INTRAMUSCULAR
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021320
Product Number: 001
Approval Date: Nov 25, 2003
Applicant Holder Full Name: SPECIALITY EUROPEAN PHARMA LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
